PASITHEA THERAPEUTICS CORP. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PASITHEA THERAPEUTICS CORP. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $358.04K.
- PASITHEA THERAPEUTICS CORP. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $1.65M.
- PASITHEA THERAPEUTICS CORP. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $1.21M.
- PASITHEA THERAPEUTICS CORP. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $14.60K.
- PASITHEA THERAPEUTICS CORP. stock issued during period, value, new issues for fiscal 2025 was $2.08M.
- PASITHEA THERAPEUTICS CORP. stock issued during period, value, new issues for fiscal 2023 was $71.74K, a 25.21% decline from fiscal 2022.
- PASITHEA THERAPEUTICS CORP. stock issued during period, value, new issues for fiscal 2022 was $95.91K, a 92.07% decline from fiscal 2021.
- PASITHEA THERAPEUTICS CORP. stock issued during period, value, new issues for fiscal 2021 was $1.21M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $2.08M 10-K · filed 2026-03-30 | |
| 2025-06-30 | $358.04K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $1.65M 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $71.74K 10-K · filed 2024-03-29 | |
| 2022-12-31 | $95.91K 10-K · filed 2024-03-29 | |
| 2021-12-31 | $1.21M 10-K · filed 2023-03-30 | |
| 2021-03-31 | $1.21M 10-Q · filed 2022-11-14 | |
| 2020-09-30 | $14.60K 10-Q · filed 2021-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |